Frailty prediction in patients with chronic digestive system diseases: based on multi-task learning model

基于多任务学习模型的慢性消化系统疾病患者虚弱预测

阅读:2

Abstract

BACKGROUND: Chronic digestive system diseases (CDSD) pose a major health challenge worldwide, significantly increasing morbidity and mortality rates. The frailty index is crucial for assessing patient prognosis. To address the need for proactive healthcare, we developed a multi-timepoint frailty prediction model. METHODS: This study collected data from 565 patients with CDSD, including their frailty assessments at 3 and 6 years of follow-up. Utilizing the Multi-Gate Mixture-of-Experts (MMoE) framework, we built and evaluated five models: Tab Transformer, Convolutional Neural Network (CNN), Deep Neural Network (DNN), Extreme Gradient Boosting (XGBoost) and Random Forest (RF). We comprehensively compared the predictive capabilities of these models on both validation and test sets. RESULTS: The MMoE framework consistently outperforms single models in predicting both 3-year and 6-year frailty indices across most metrics. Specifically, for 3-year predictions, the single model achieves an accuracy of 0.9801 (95% CI: 0.963-0.990) on the train set and 0.5487 (95% CI: 0.457-0.637) on the test set, while the MMoE model reaches 0.956 (95% CI: 0.933-0.971) and 0.982 (95% CI: 0.938-0.995), respectively. The RF model demonstrated perfect performance, with Micro-AUC values of 1.000 in both training and test sets for both 3-year and 6-year intervals, leading other models in terms of accuracy, precision, recall, F1 score. The Tab Transformer model achieved high Micro-AUC values across all prediction intervals, with values of 0.997 and 0.995 in the training set for 3-year and 6-year predictions, respectively, and corresponding test set values of 0.999 and 0.987. CONCLUSION: This MMoE-based approach can predict frailty at key time points, offering insights into frailty progression and aiding clinical decision making. Integrating this AI model into CDSD management can promote early interventions and personalized treatment plans.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。